Page last updated: 2024-09-05

donitriptan and substance p

donitriptan has been researched along with substance p in 1 studies

Compound Research Comparison

Studies
(donitriptan)
Trials
(donitriptan)
Recent Studies (post-2010)
(donitriptan)
Studies
(substance p)
Trials
(substance p)
Recent Studies (post-2010) (substance p)
130417,2892772,010

Protein Interaction Comparison

ProteinTaxonomydonitriptan (IC50)substance p (IC50)
Substance-P receptorRattus norvegicus (Norway rat)0.0005
Substance-K receptorRattus norvegicus (Norway rat)0.2
Substance-K receptorHomo sapiens (human)0.2455
Substance-P receptorHomo sapiens (human)0.0011
Neuromedin-K receptorHomo sapiens (human)0.125
Substance-K receptorMesocricetus auratus (golden hamster)0.148

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Avezaat, CJ; Bogers, AJ; John, GW; MaassenVanDenBrink, A; Mulder, PG; Saxena, PR; van den Broek, RW1

Other Studies

1 other study(ies) available for donitriptan and substance p

ArticleYear
Comparison of contractile responses to donitriptan and sumatriptan in the human middle meningeal and coronary arteries.
    European journal of pharmacology, 2002, May-17, Volume: 443, Issue:1-3

    Topics: Adult; Aged; Coronary Vessels; Dose-Response Relationship, Drug; Female; Humans; In Vitro Techniques; Male; Meningeal Arteries; Middle Aged; Muscle Relaxation; Muscle, Smooth, Vascular; Nitriles; Piperazines; Predictive Value of Tests; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Substance P; Sumatriptan; Tryptamines; Vasoconstrictor Agents

2002